Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule.
作者信息
Abrouk Michael, Beroukhim Kourosh, Nakamura Mio, Zhu Tian Hao, Farahnik Benjamin, Singh Rasnik, Brodsky Merrick, Lee Kristina, Koo John, Bhutani Tina
机构信息
Irvine School of Medicine, University of California, Irvine, CA.
David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA.
出版信息
Int J Womens Dermatol. 2016 Mar 2;2(2):62-64. doi: 10.1016/j.ijwd.2016.02.001. eCollection 2016 Jun.
Abstract
摘要
相似文献
1
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule.
Int J Womens Dermatol. 2016 Mar 2;2(2):62-64. doi: 10.1016/j.ijwd.2016.02.001. eCollection 2016 Jun.
2
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule.
Int J Womens Dermatol. 2017 Feb 16;3(1 Suppl):S67-S69. doi: 10.1016/j.ijwd.2017.02.014. eCollection 2017 Mar.
3
Update on biologic safety for patients with psoriasis during pregnancy.
Int J Womens Dermatol. 2017 Feb 4;3(1):21-25. doi: 10.1016/j.ijwd.2016.12.003. eCollection 2017 Mar.
4
Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Fed Regist. 2014 Dec 4;79(233):72063-103.
5
The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
J Midwifery Womens Health. 2017 May;62(3):308-316. doi: 10.1111/jmwh.12611. Epub 2017 May 29.
6
Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Dermatol Online J. 2015 Nov 18;21(11):13030/qt46c4m2tw.
7
Medication use in pregnancy and the pregnancy and lactation labeling rule.
Clin Pharmacol Ther. 2016 Jul;100(1):23-5. doi: 10.1002/cpt.380. Epub 2016 May 9.
8
Recent changes in pregnancy and lactation labeling: retirement of risk categories.
Pharmacotherapy. 2014;34(4):389-95. doi: 10.1002/phar.1385. Epub 2014 Jan 4.
9
Considerations for assessing the cost of biologic agents in the treatment of psoriasis.
J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S38-41.
10
An overview of upcoming changes in pregnancy and lactation labeling information.
Pharm Pract (Granada). 2015 Apr-Jun;13(2):605. doi: 10.18549/pharmpract.2015.02.605. Epub 2015 Jun 15.
引用本文的文献
1
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.
Am J Clin Dermatol. 2021 Jul;22(4):425-442. doi: 10.1007/s40257-021-00603-w. Epub 2021 Apr 16.
2
Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.
An Bras Dermatol. 2019 Apr;94(2 Suppl 1):76-107. doi: 10.1590/abd1806-4841.2019940211. Epub 2019 Jun 30.
本文引用的文献
1
Preventing hepatitis B reactivation associated with immunosuppressive drug treatments for psoriasis.
J Am Acad Dermatol. 2015 Nov;73(5):881-2. doi: 10.1016/j.jaad.2015.07.023.
2
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
N Engl J Med. 2015 Oct;373(14):1318-28. doi: 10.1056/NEJMoa1503824.
3
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.
4
New systemic therapies for psoriasis.
Cutis. 2015 Mar;95(3):155-60.
5
Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Fed Regist. 2014 Dec 4;79(233):72063-103.
6
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.
Br J Dermatol. 2015;172(5):1371-83. doi: 10.1111/bjd.13469. Epub 2015 Mar 22.
7
Trends in pregnancy labeling and data quality for US-approved pharmaceuticals.
Am J Obstet Gynecol. 2014 Dec;211(6):690.e1-11. doi: 10.1016/j.ajog.2014.06.013. Epub 2014 Jun 6.
8
Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.
J Clin Pharm Ther. 2014 Jun;39(3):307-13. doi: 10.1111/jcpt.12148. Epub 2014 Mar 17.
9
Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation.
J Am Acad Dermatol. 2012 Sep;67(3):459-77. doi: 10.1016/j.jaad.2011.07.039. Epub 2011 Oct 22.
10
[Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment].
Z Rheumatol. 2010 Dec;69(10):903-9. doi: 10.1007/s00393-010-0652-y.
Zotero 插件